Literature DB >> 17048114

Analytical tools and approaches for metabolite identification in early drug discovery.

Yuan Chen1, Mario Monshouwer, William L Fitch.   

Abstract

Determination of the chemical structures of metabolites is a critical part of the early pharmaceutical discovery process. Understanding the structures of metabolites is useful both for optimizing the metabolic stability of a drug as well as rationalizing the drug safety profile. This review describes the current state of the art in this endeavor. The likely outcome of metabolism is first predicted by comparison to the literature. Then metabolites are synthesized in a variety of in vitro systems. The various approaches to LC/UV/MS are applied to learn information about these metabolites and structure hypotheses are made. Structures are confirmed by synthesis or NMR. The special topic of reactive metabolite structure determination is briefly addressed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048114     DOI: 10.1007/s11095-006-9162-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  84 in total

Review 1.  Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.

Authors:  Svava Osk Jónsdóttir; Flemming Steen Jørgensen; Søren Brunak
Journal:  Bioinformatics       Date:  2005-02-15       Impact factor: 6.937

2.  The combination of liquid chromatography/tandem mass spectrometry and chip-based infusion for improved screening and characterization of drug metabolites.

Authors:  Roland F Staack; Emmanuel Varesio; Gérard Hopfgartner
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

3.  Simultaneously quantifying parent drugs and screening for metabolites in plasma pharmacokinetic samples using selected reaction monitoring information-dependent acquisition on a QTrap instrument.

Authors:  Austin C Li; Dennis Alton; Matthew S Bryant; Wilson Z Shou
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

4.  Microreactor microfluidic systems with human microsomes and hepatocytes for use in metabolite studies.

Authors:  Jeanna C Zguris; Laura J Itle; Daniel Hayes; Michael V Pishko
Journal:  Biomed Microdevices       Date:  2005-06       Impact factor: 2.838

5.  Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS.

Authors:  Mona I Churchwell; Nathan C Twaddle; Larry R Meeker; Daniel R Doerge
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-07-05       Impact factor: 3.205

6.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

7.  Characterization and quantification of metabolites of racemic ketoprofen excreted in urine following oral administration to man by 1H-NMR spectroscopy, directly coupled HPLC-MS and HPLC-NMR, and circular dichroism.

Authors:  E Skordi; I D Wilson; J C Lindon; J K Nicholson
Journal:  Xenobiotica       Date:  2004 Nov-Dec       Impact factor: 1.908

8.  Characterization of a novel metabolite intermediate of ziprasidone in hepatic cytosolic fractions of rat, dog, and human by ESI-MS/MS, hydrogen/deuterium exchange, and chemical derivatization.

Authors:  Zhuang Miao; Amin Kamel; Chandra Prakash
Journal:  Drug Metab Dispos       Date:  2005-04-08       Impact factor: 3.922

9.  Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.

Authors:  Andreas H Ewald; Frank T Peters; Magdalene Weise; Hans H Maurer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-25       Impact factor: 3.205

Review 10.  Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

Authors:  M J Gómez-Lechón; M T Donato; J V Castell; R Jover
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

View more
  5 in total

1.  Chromatographic assays of drug oxidation by human cytochrome P450 3A4.

Authors:  Christal D Sohl; Qian Cheng; F Peter Guengerich
Journal:  Nat Protoc       Date:  2009-08-06       Impact factor: 13.491

2.  Advances in structure elucidation of small molecules using mass spectrometry.

Authors:  Tobias Kind; Oliver Fiehn
Journal:  Bioanal Rev       Date:  2010-08-21

3.  A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.

Authors:  Hetal N Prajapati; Damon M Dalrymple; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2011-08-23       Impact factor: 4.200

4.  Combined Liquid Chromatography-Infrared Ion Spectroscopy for Identification of Regioisomeric Drug Metabolites.

Authors:  Jonathan Martens; Valerie Koppen; Giel Berden; Filip Cuyckens; Jos Oomens
Journal:  Anal Chem       Date:  2017-04-03       Impact factor: 6.986

5.  Metabolite Identification of HIV-1 Capsid Modulators PF74 and 11L in Human Liver Microsomes.

Authors:  Shujing Xu; Lin Sun; Dang Ding; Xujie Zhang; Xinyong Liu; Peng Zhan
Journal:  Metabolites       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.